LifeLabs Medical Laboratory Services

LifeLabs Medical Laboratory Services

June 05, 2015 11:30 ET

LifeLabs Partnering With Princess Margaret Cancer Centre to Provide Comprehensive Genomic Profiling to Thousands of Canadian Cancer Patients

TORONTO, ONTARIO and VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 5, 2015) -

Attention Business & Healthcare Editors

LifeLabs Medical Laboratory Services ("LifeLabs") today joined the Federal Department of State (Science and Technology), Genome Canada and the Princess Margaret Cancer Centre to announce the partnership between LifeLabs and the Princess Margaret Cancer Centre to establish a national database of genomic profiles of various cancers.

By establishing a genomic profile database, healthcare providers will have access to information that will allow them to offer the right drug at the right time to cancer patients, improving cancer treatment outcomes for Canadians coast to coast and achieving substantial cost-savings in the healthcare system for multiple cancer types.

"Genetics is revolutionizing 21st century healthcare and LifeLabs is committed to making clinically relevant genetic testing more accessible to Canadians," said Sue Paish, LifeLabs' President and CEO. "With our partnership with the Princess Margaret Cancer Centre and the University Health Network together we will help transform cancer treatment in Canada. We are grateful to Genome Canada and the Federal Government for their support for innovation and research in genomics through the Genomic Applications Partnership Program. We are also honoured to be partnering with such esteemed organizations as Princess Margaret and UHN."

Through collaborations with recognized and knowledgeable partners across academic, research and delivery sectors and with the development of a new purpose-built state-of-the-art genetic testing laboratory, LifeLabs offers a comprehensive menu of genetic tests focused on cancer, non-invasive prenatal testing, rare inherited conditions, and pharmacogenomics.

"As this new era of personalized medicine evolves, LifeLabs is thrilled to be partnering again with the Princess Margaret Cancer Centre," said Jeff Sumner, LifeLabs' Senior Vice-President, Business Development, Clinical Affairs and Genetics. "Our strengths in efficient laboratory operations, specimen collection, transportation and extensive logistics capabilities and rapidly growing genetic testing capabilities, combined with the Princess Margaret Cancer Centre's expertise as Canada's leading developer of novel cancer genomic assays, will bring a comprehensive cancer genomics strategy to Canada."

About LifeLabs: www.LifeLabs.com

LifeLabs is a Canadian-owned company with over 50 years of experience providing laboratory testing services to help healthcare providers diagnose, treat, monitor and prevent disease. In communities across British Columbia and Ontario, LifeLabs provides cost-effective, convenient access to laboratory testing services which are essential for optimal outcomes in healthcare. LifeLabs employs approximately 5,400 professionally trained staff and delivers over 100 million laboratory tests, serving 19 million patient visits annually. In 2013, LifeLabs acquired BC Biomedical in British Columbia and CML HealthCare in Ontario making LifeLabs the largest community laboratory in Canada. LifeLabs is indirectly owned by OMERS Administration Corporation, whose interest is managed by Borealis Infrastructure. For more information about LifeLabs Genetics visit www.LifeLabsGenetics.com. LifeLabs is a Proud Supporter of the TORONTO 2015 Pan Am/Parapan Am Games.

About Borealis Infrastructure: www.borealis.ca

Borealis Infrastructure is a leader in direct infrastructure investing with over a decade of investment experience. Borealis manages more than $12 billion in OMERS equity capital through investments in a diversified portfolio of large-scale infrastructure assets exhibiting stability and strong cash flows, in sectors including energy, transportation and social infrastructure. It has offices in Toronto, London, New York and Sydney. Borealis is the infrastructure investment arm of OMERS, one of Canada's largest pension funds with net assets of more than $72 billion and an AAA credit rating. For more information please visit www.borealis.ca or www.omers.com.

Contact Information